Table of Contents
PHILADELPHIA – Rite Aid Corp. announced Thursday that the New York Stock Exchange informed the company that it is no longer in compliance with NYSE continued listing standards set forth in Section 802.01B (the Minimum Market Capitalization Standard), and Section 802.01C (the Minimum Stock Price Standard) of the NYSE’s Listed Company Manual.
“Under the NYSE rules, the company is provided with certain cure periods and the company’s common stock will continue to be listed and traded on the NYSE during the cure periods, subject to the company’s compliance with other continued listing requirements,” Rite Aid said Wednesday in a statement. “The current noncompliance with the NYSE listing standards does not affect the company’s ongoing business operations or its U.S. Securities and Exchange Commission reporting requirements, nor does it trigger any violation of its material debt or other obligations.”
The retailer said it was looking at several options.
“The company has been engaged in reviewing and continues to review strategic alternatives to recapitalize, refinance or otherwise optimize its capital structure, which may ultimately result in the company pursuing one or more significant corporate transactions or other remedial measures,” Rite Aid said. “The ongoing review includes an evaluation of available options to regain compliance with the NYSE’s continued listing standards. The company can provide no assurances that it will be able to regain compliance with the NYSE’s continued listing standards or otherwise and maintain the listing of its shares on the NYSE or the results of the ongoing review.”
